TD Asset Management Inc

Position in IMNM — Immunome Inc.

CIK 1056053 Toronto, A6

Position in IMNM

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$15,241,373

+$43,167 QoQ

Shares Held

719,272

+3.5% QoQ

Ownership

0.633%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#28

of 200 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. IMNM ranks #18 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	259,317	$161,694,522
2	VRTX	Vertex Pharmaceuticals Inc / Ma	207,960	$103,299,970
3	HALO	Halozyme Therapeutics, Inc.	1,115,730	$87,328,187
4	ALNY	Alnylam Pharmaceuticals, Inc.	233,696	$70,349,506
5	CYTK	Cytokinetics Inc	385,130	$32,809,224
6	RPRX	Royalty Pharma plc	567,497	$31,819,556
7	ASND	Ascendis Pharma A/S	119,085	$31,762,351
8	KYMR	Kymera Therapeutics, Inc.	272,900	$31,293,443

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,241,373	719,272	+3.5%	Shares	Sole	2026-08-04
2026-03-31	$15,198,206	694,934	-8.5%	Shares	Sole	2026-05-11
2025-12-31	$16,307,444	759,192	+8.3%	Shares	Sole	2026-02-10
2025-09-30	$8,211,988	701,280	+15.8%	Shares	Sole	2025-11-10
2025-06-30	$5,631,429	605,530	-0.2%	Shares	Sole	2025-07-28
2025-03-31	$4,083,508	606,762	+43.3%	Shares	Sole	2025-05-07
2024-12-31	$4,495,467	423,302	+7.3%	Shares	Sole	2025-02-11
2024-09-30	$5,769,315	394,618	+21.3%	Shares	Sole	2024-11-01
2024-06-30	$3,934,992	325,206	+13.8%	Shares	Sole	2024-08-02
2024-03-31	$7,053,692	285,806	+124.5%	Shares	Sole	2024-05-08
2023-12-31	$1,361,896	127,280	0.0%	Shares	Sole	2024-02-12
2023-09-30	$1,062,788	127,280	—	Shares	Sole	2023-10-27
No filing history on record for this holder in this stock.